![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
Learning 500 Chinese characters in 30 days is possible. |
| Valvular Heart Disease |
|
Free Subscription
3 Am J Cardiol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Valvular Heart Disease is free of charge.
GLP-1 Receptor Agonist and SGLT2 inhibitor use and Transcatheter Aortic Valve
Replacement Outcomes: A Critique and Partial Re-Analysis.
Am J Cardiol. 2026 Mar 8:S0002-9149(26)00152.
PubMed
Valvular Heart Disease during Pregnancy: Outcomes from a Large Integrated
Healthcare System.
Am J Cardiol. 2026 Mar 7:S0002-9149(26)00149.
PubMed
Abstract available
Association of GLP-1 Receptor Agonist and SGLT2 Inhibitor with Cardiovascular
Outcomes after Transcatheter Aortic Valve Replacement.
Am J Cardiol. 2026 Feb 27:S0002-9149(26)00087.
PubMed
Abstract available
Comparison of Repair vs Replacement in Calcific and Rheumatic Mitral Disease.
Ann Thorac Surg. 2023;116:954-961.
PubMed
Abstract available
Transcervical Robotic Aortic Valve Replacement: A Possible New Frontier in
Cardiac Surgery?
Ann Thorac Surg. 2026 Mar 10:S0003-4975(26)00209.
PubMed
Abstract available
Trends in Utilization and Outcomes of Ross, Transcatheter and Surgical Aortic
Valve Replacement in Adults Younger Than 65 Years Old.
Ann Thorac Surg. 2026 Feb 26:S0003-4975(26)00155.
PubMed
Abstract available
Transcatheter Aortic Valve Implantation in Complex Aortic Pathology: Managing
Aortic Regurgitation With Chronic Dissection and Previous Endovascular Repair.
Catheter Cardiovasc Interv. 2026 Mar 1. doi: 10.1002/ccd.70526.
PubMed
Abstract available
Long-Term Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve
Replacement in Patients With Small Aortic Annuli.
Catheter Cardiovasc Interv. 2026 Mar 1. doi: 10.1002/ccd.70533.
PubMed
Abstract available
Annular Ellipticity and Sizing Strategy in Transcatheter Aortic Valve
Implantation: Independent or Combined Risk Patterns?
Catheter Cardiovasc Interv. 2026 Mar 1. doi: 10.1002/ccd.70540.
PubMed
Abstract available
Effect of Basal Septal Hypertrophy on TAVR Outcomes: Evidence From a Large Cohort
Study.
Catheter Cardiovasc Interv. 2026;107:1267-1276.
PubMed
Abstract available
Patient-Specific Strategy for Coronary Alignment in TAVI With Evolut FX.
Catheter Cardiovasc Interv. 2026;107:1112-1119.
PubMed
Abstract available
Impact of Peri-Procedural Red Blood Cell Transfusion on Clinical Outcomes in
Transcatheter Aortic Valve Replacement: A Propensity-Matched Cohort Study.
Catheter Cardiovasc Interv. 2026 Mar 9. doi: 10.1002/ccd.70554.
PubMed
Abstract available
Five-Year Clinical and Hemodynamic Evaluation of the Hydra Self-Expanding
Transcatheter Heart Valve in Patients With Severe Aortic Stenosis.
Catheter Cardiovasc Interv. 2026 Mar 2. doi: 10.1002/ccd.70536.
PubMed
Abstract available
Hemodynamic and Metabolic-Inflammatory Phenotyping Across the Cardiac Index
Spectrum in Moderate and Severe Tricuspid Regurgitation: Prognostic Implications.
Circ Cardiovasc Imaging. 2026 Mar 6:e019444. doi: 10.1161/CIRCIMAGING.125.019444
PubMed
Abstract available
Ruptured Left Sinus of Valsalva Aneurysm With Concomitant Aortic Stenosis Treated
by TAVR: CT and TEE Findings.
Circ Cardiovasc Imaging. 2026 Mar 13:e019498.
PubMed
Paradox of Elevated Gradients After Valve-in-Valve Transcatheter Aortic Valve
Implantation.
Circ Cardiovasc Interv. 2026 Mar 4:e016577.
PubMed
PRMT3-Mediated Arginine Methylation Stabilizes PCSK9 to Promote Aortic Valve
Calcification.
Circulation. 2026 Mar 9. doi: 10.1161/CIRCULATIONAHA.125.078830.
PubMed
Abstract available
Correction to: Transcatheter edge-to-edge repair vs medical therapy in atrial
functional mitral regurgitation: a propensity score-based comparison from the
OCEAN-Mitral and REVEAL-AFMR registries.
Eur Heart J. 2026 Mar 11:ehag190. doi: 10.1093.
PubMed
Valvular heart disease: challenges and opportunity.
Eur Heart J. 2026;47:1271-1275.
PubMed
The ESC Council on Valvular Heart Disease today and the vision for tomorrow.
Eur Heart J. 2026 Mar 13:ehag094. doi: 10.1093.
PubMed
Wearable acoustic cardiography: a novel non-invasive digital sentinel for
subclinical leaflet thrombosis after transcatheter aortic valve replacement.
Eur Heart J. 2026 Mar 13:ehag156. doi: 10.1093.
PubMed
Pregnancy with a prosthetic heart valve, thrombosis, and bleeding: the ESC EORP
Registry of Pregnancy and Cardiac disease III.
Eur Heart J. 2026;47:1318-1335.
PubMed
Abstract available
Valvular heart failure: evolving pharmacological approaches.
Eur Heart J. 2026 Jan 13:ehaf1079. doi: 10.1093/eurheartj/ehaf1079.
PubMed
Abstract available
20-Year Experience With Decellularized Pulmonary Homografts for Pulmonary Valve
Replacement.
Eur J Cardiothorac Surg. 2026;68:ezag087.
PubMed
Abstract available
Rare cardiac outpouching in rheumatic mitral valve disease.
Heart. 2026;112:409-410.
PubMed
Impact of advanced cardiac damage in severe aortic stenosis on short-term and
mid-term mortality and rehospitalisation after transcatheter aortic valve
implantation: a systematic review and meta-analysis.
Heart. 2026 Mar 6:heartjnl-2025-326941. doi: 10.1136/heartjnl-2025-326941.
PubMed
Abstract available
Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A
CMR-based head-to-head comparison and outcome analysis.
Int J Cardiol. 2023;393:131357.
PubMed
Abstract available
Association of duration and intensity of exercise with phenotypic expression in
hypertrophic cardiomyopathy.
Int J Cardiol. 2023;392:131253.
PubMed
Abstract available
Genotype-Guided Risk Stratification of Mitral Valve Surgery in Marfan Syndrome.
J Am Coll Cardiol. 2026 Mar 4:S0735-1097(26)00238.
PubMed
Abstract available
Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain,
Patient-Level Analysis of the MAPLE-HCM Trial.
J Am Coll Cardiol. 2026;87:1029-1042.
PubMed
Abstract available
Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in
Obstructive Hypertrophic Cardiomyopathy.
J Am Coll Cardiol. 2026;87:1046-1058.
PubMed
Abstract available
Beta-Blocker (Bisoprolol) vs Calcium-Channel Blocker (Verapamil) in
Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Triple-Crossover
Physiologic Trial.
J Am Coll Cardiol. 2026;87:1063-1083.
PubMed
Abstract available
Myocardial Work in Apical Hypertrophic Cardiomyopathy.
J Am Soc Echocardiogr. 2023;36:1043-1054.
PubMed
Abstract available
Sex-Specific Considerations for Mitral Valve Intervention: An Opportunity for
Collaboration.
J Am Soc Echocardiogr. 2026 Mar 6:S0894-7317(26)00088.
PubMed
A Nudge in the Right Direction: Improving Care Pathways in Severe Aortic
Stenosis.
J Am Soc Echocardiogr. 2026 Mar 3:S0894-7317(26)00086.
PubMed
Commentary: Are small aortic valves bad? Definitely! Maybe... It depends?
J Thorac Cardiovasc Surg. 2026;171:590-591.
PubMed
Micro-invasive, off-pump, trans-ventricular neochordae implantation in recurrent
mitral valve regurgitation after open heart surgical repair.
J Thorac Cardiovasc Surg. 2026 Feb 26:S0022-5223(26)00174.
PubMed
Abstract available
Accessory Mitral Valve Tissue: A 15-Year Single-Center Pediatric Experience.
Pediatr Cardiol. 2026 Mar 7. doi: 10.1007/s00246-025-04143.
PubMed
Symptom experiences of patients after cardiac valve surgery: A qualitative study.
PLoS One. 2026;21:e0342597.
PubMed
Abstract available
Thank you for your interest in scientific medicine.